- Investing Ideas
- Indian Pharmaceuticals & Biotech Potentially Undervalued Small Caps
Indian Pharmaceuticals & Biotech Potentially Undervalued Small Caps
Results
8
Value score of at least 4 focused on companies with a low market cap.
8 companies
Cian Healthcare
Market Cap: ₹206.5m
Engages in the research, development, manufacture, marketing, and sale of pharmaceutical products in India.
542678
₹8.26
7D
0%
1Y
108.1%
Sotac Pharmaceuticals
Market Cap: ₹1.2b
Engages in the production, manufacturing, processing, and sale of various pharmaceutical products in India.
SOTAC
₹111.00
7D
0%
1Y
-11.9%
Brooks Laboratories
Market Cap: ₹2.0b
Provides contract development and manufacturing services for pharmaceutical companies in India and internationally.
BROOKS
₹67.05
7D
13.2%
1Y
-54.4%
Amwill Health Care
Market Cap: ₹720.9m
A derma-cosmetic company, engages in the development and contract manufacturing of generic dermatological solutions in India.
544353
₹36.04
7D
11.3%
1Y
-54.2%
Coral Laboratories
Market Cap: ₹1.8b
Manufactures and sells pharmaceutical formulations in India, Ethiopia, and internationally.
524506
₹506.30
7D
2.7%
1Y
-19.5%
Vikram Thermo (India)
Market Cap: ₹5.5b
Engages in the manufacture, marketing, and export of pharmaceutical excipients and chemicals in India and internationally.
530477
₹176.85
7D
10.2%
1Y
4.8%
Par Drugs and Chemicals
Market Cap: ₹1.1b
Develops, manufactures, and sells active pharmaceutical ingredients (APIs) and fine chemicals in India.
PAR
₹89.47
7D
-3.1%
1Y
-10.5%
Sunil Healthcare
Market Cap: ₹646.0m
Engages in the manufacture and sale of empty hard gelatin, hydroxypropyl methylcellulose (HPMC), and pullulan capsules shells in India and internationally.
537253
₹63.00
7D
-1.0%
1Y
-13.8%